Ascendis Pharma A/S vs Monster Beverage Corp — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Monster Beverage Corp trades at $45.53 (market cap $89.20B). The key difference: Monster Beverage Corp is far larger — about 5.4× Ascendis Pharma A/S's market cap. Which is the better fit depends on your goals.
| ASND | MNST | |
|---|---|---|
Market Cap | $16.67B | $89.20B |
Sector | Health | Consumer Staples |
52-Week High | $277.18 | $49.97 |
52-Week Low | $189.74 | $30.86 |
Enterprise Value | $17.04B | $87.49B |
Trailing returns across standard periods
Latest headlines on both assets
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →